Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.48.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BU.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EW.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FB.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CJ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBF.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.11.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.101NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used